Hybrid Coronary Percutaneous Treatment With Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results From the GABI-R Registry
Journal of Clinical Medicine
doi 10.3390/jcm8060767
Full Text
Open PDFAbstract
Available in full text
Date
May 30, 2019
Authors
Publisher
MDPI AG